JAVELIN Renal 101: Combination Therapy vs Standard of Care in Advanced RCC

Research presented at ASCO GU 2019 compared PFS with avelumab and axitinib vs sunitinib in patients with advanced renal cell carcinoma.

Source: CancerNetwork - March 6, 2019 Category: Cancer & Oncology Authors: John Schieszer Source Type: news